drugset / Trial / NCT04129697

Intratympanic Steroids for Sudden Hearing Loss

NCT04129697

RandomizedParallel-groupSingle-blindTreatment

Summary

For patients with sudden hearing loss, the initial treatment is not usually effective. We use Dexamethasone or Methylprednisolone to be an Intratympanic steroid administration as a salvage treatment. An randomized, double-blind, multi-center study is designed to find the difference between Dexamethasone or Methylprednisolone.

Timeline

Start
2020-01-01
Primary completion
2021-12-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule Other
Comparator Methylprednisolone Other / unclassified Other